STAT

FEBRUARY 22, 2024

A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents aghast, with many saying it leaves unvaccinated children especially vulnerable to the highly contagious disease. In a letter dated Tuesday about an outbreak at Manatee Bay Elementary School in Weston, located northwest of Miami and west of Fort Lauderdale, the state’s surgeon general, Joseph Ladapo, said that while it is normal policy to tell unvaccinated children to stay home during an outbrea

Vaccines 364

Vaccines 364

Pharmacy Is Right For Me

FEBRUARY 22, 2024

There is a common misconception that all community pharmacies are alike, and that most of what community pharmacists do is count pills. This could not be further from the truth and Dr. Mohanad Znbaqa’s story will demonstrate just how versatile a career practicing in a community pharmacy can be! Expanding Horizons: A Pharmacist’s Journey in Ambulatory Care Dr.

Community Pharmacies 130

Community Pharmacies Scheduling Appointments Diabetes Hospitals 130

STAT

FEBRUARY 22, 2024

When a psychology professor in Michigan looked through his data on interpersonal conflict a decade ago, he discovered something unexpected. The study , which examined differences across cultures and age groups, seemed to show Americans got wiser as they got older. Richard Nisbett was used to research showing poorer mental skills among elderly adults, but his work found they were better at recognizing multiple perspectives, encouraging compromise, and acknowledging the limits of their own knowled

363

363

PharmaVoice

FEBRUARY 22, 2024

Ferring’s U.S. president Brent Ragans discusses the company’s strategy as it expands into new therapeutic areas and further develops its reproductive pipeline.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

FEBRUARY 22, 2024

Imagine having 15 miscarriages. Maybe you can shrug off the first one or two and keep trying to have children, to create a family. But soon every positive pregnancy test brings a sense of dread, of sad inevitability. Your body becomes your enemy.

363

363

PharmaVoice

FEBRUARY 22, 2024

Leading AbbVie to become one of the most successful pharmas in the world, Gonzalez also rubbed some critics the wrong way.

130

130

BioPharma Dive

FEBRUARY 22, 2024

The startup’s Series C round will support a clinical-stage drug the company thinks could address some of the weaknesses of other KRAS-targeting medicines.

122

122

STAT

FEBRUARY 22, 2024

In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies. But as the country marks two years this week since the invasion — and as the war has dragged on without a clear end in sight — Ukrainian researchers and executives are increasingly urging companies to restart clinical trials, insisting that the advantages that lured drugmakers in the first pl

Drug Development 358

Drug Development 358

pharmaphorum

FEBRUARY 22, 2024

Discover how AI, automation, and blockchain technologies are revolutionising pharmaceutical case processing in compliance with FDA regulations. Explore the benefits of these advancements in this insightful article.

115

115

STAT

FEBRUARY 22, 2024

The U.S. Food and Drug Administration told an advocacy group that it is not planning to take a tougher stance against wayward clinical trial sponsors and investigators that fail to register studies or report results, a central issue in the ongoing debate over greater transparency into clinical research. In response to a citizen’s petition filed a year ago, the agency indicated it is unlikely to levy fines or take a more stringent approach to issue so-called non-compliance notices because

347

347

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Pharmacist

FEBRUARY 22, 2024

Just 52% of pharmacists enjoy ‘some aspects’ of their work or study, a new wellbeing survey from the Royal Pharmaceutical Society (RPS) and charity Pharmacist Support has found. And nearly nine in 10 pharmacists are at high risk of burnout, the survey suggested, prompting calls to address the underlying factors contributing to poor mental health […] The post Only half of pharmacists enjoy their work, survey suggests appeared first on The Pharmacist.

113

113

STAT

FEBRUARY 22, 2024

Community Health Systems is facing a new federal probe into its hospital billing practices more than four years after the hospital chain settled separate allegations of fraudulent overbilling. CHS, a national system of 71 rural and suburban hospitals, said this week it received a civil investigative demand from the Department of Justice on Jan. 11. Federal investigators asked CHS to hand over documents that covered “practices and procedures related to utilization review, inpatient admissi

Hospitals 324

Hospitals Inpatient Documentation 324

Pharmaceutical Commerce

FEBRUARY 22, 2024

A cohort study investigates how a change in clinical guidelines, an expanded label, and reduction in drug prices can impact the use of PCSK9 inhibitors as a treatment for atherosclerotic cardiovascular disease.

Drug Pricing 104

Drug Pricing Labelling 104

STAT

FEBRUARY 22, 2024

After a contentious dispute, Novavax has agreed to refund up to $400 million to the international organization that purchased Covid-19 shots as part of a global vaccination program, but found itself with vaccines that were no longer needed. The agreement caps a disconcerting episode involving several vaccine makers and Gavi, the Vaccine Alliance, a public-private partnership that worked with the World Health Organization as the Covid-19 pandemic erupted four years ago to bring Covid shots to low

Vaccines 319

Vaccines 319

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

European Pharmaceutical Review

FEBRUARY 22, 2024

A report by Towards Healthcare has forecasted that the advanced drug delivery market will value $375.86 billion by 2033. The year 2023 was “significant” for the progress of advanced drug delivery systems, the author reflected. Last year, with a size of $234.84 billion, the market witnessed “remarkable advancements that promise to reshape healthcare landscapes across the globe”.

98

98

STAT

FEBRUARY 22, 2024

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with. Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software.

Hospitals 316

Hospitals 316

European Pharmaceutical Review

FEBRUARY 22, 2024

The National Institute for Health and Care Excellence (NICE) has recommended LITFULO ® (ritlecitinib) for treating certain patients with severe alopecia areata. This is “an important milestone” according to Lynn Clay, Specialty Care Lead at Pfizer UK. The once daily oral capsule is indicated as a treatment option in individuals who are 12 years and older.

98

98

STAT

FEBRUARY 22, 2024

One of us, Jeffrey M., is on weekend call for our office-based internal medicine practice. It is midafternoon, and a patient leaves a message with our answering service — she is concerned about her mother’s respiratory symptoms. So, Jeffrey interrupts his late lunch and rings her back. As she explains that her 96-year-old mother has a harsh cough and nasal congestion, he hears both the facts and the worry in her voice.

Hospitals 299

Hospitals 299

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

FEBRUARY 22, 2024

In a dynamic healthcare market, securing top talent is essential for the success of any organisation. Advanced Clinical looks at innovative recruitment strategies and solutions to help you attract and retain the best healthcare professionals.

107

107

STAT

FEBRUARY 22, 2024

What do CEOs owe the world? Did Humira break the system? And can you CRISPR a fetus? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, former Alnylam Pharmaceuticals CEO John Maraganore and STAT’s Matthew Herper join us to discuss the legacy of AbbVie chief executive Richard Gonzalez, who announced his retirement this week.

268

268

Pharma Times

FEBRUARY 22, 2024

The trial is recruiting patients in Leeds, Manchester, Oxford, London, Cambridge and Kent

Hospitals 132

Hospitals 132

STAT

FEBRUARY 22, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, all. Damian here with an update on the plight of the  other  Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

Vaccines 253

Vaccines Drug Pricing Drug Development 253

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

FEBRUARY 22, 2024

NICE has backed NHS use of Pfizer’s Litfulo for patients with alopecia areata, the first drug therapy for a condition that affects around 14,000 people

105

105

STAT

FEBRUARY 22, 2024

Top of the morning to you, and a fine one it is. Clear blue skies are hovering over the Pharmalot campus, where a cool breeze is wafting by and the official mascots are bounding about the grounds in search of critters. As for us, we are engaged in the usual rituals of brewing cups of stimulation — our choice today is orange creme — and foraging for items of interest.

Vaccines 238

Vaccines 238

The Pharmacist

FEBRUARY 22, 2024

Integrated care boards (ICBs) are considering whether to recommend primary care networks (PCNs) switch patients with atrial fibrillation from edoxaban onto apixaban. NHS England advised commissioners last month (16 January) to consider developing a local policy to review direct oral anticoagulant (DOAC) prescriptions among patients. In its commissioning guidance, it stated that clinicians should use the ‘best […] The post ICBs considering advising PCNs to switch patients onto apixaban appe

98

98

STAT

FEBRUARY 22, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. A litmus test for states’ drug pricing power Colorado could soon cap how much the state will pay for Amgen’s autoimmune drug Enbrel — in what would be the first such move from a state prescription drug affordability board.

Drug Pricing 230

Drug Pricing Hospitals 230

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

pharmaphorum

FEBRUARY 22, 2024

On today’s episode of the pharmaphorum podcast, Jason Park, CEO of Empress Therapeutics, discusses his company's novel approach to small molecule drug discovery.

109

109

Outsourcing Pharma

FEBRUARY 22, 2024

The National Institute for Health and Care Excellence (NICE) has issued guidance recommending GSK's Omjjara (momelotinib) as a treatment option for disease-related splenomegaly.

101

101

pharmaphorum

FEBRUARY 22, 2024

Stay updated on the latest clinical trials happening from 29th January to 2nd February 2024. Explore trials by Vidac, Orion, Revolo Biotherapeutics, and Uvax Bio.

109

109

Express Pharma

FEBRUARY 22, 2024

Takeda has decided to discontinue the development programs of its four oncology assets—Phase III asset modakafusp alfa (TAK-573) and three Phase I chimeric antigen receptor (CAR-T) assets: TAK-102, TAK-103 and TAK-940—as part of a plan to align its focus on advancing allogeneic cell therapies. Despite these adjustments, the Japan-based pharma major’s oncology pipeline remains robust, says GlobalData.

Immunization 105

Immunization Immunity 105

pharmaphorum

FEBRUARY 22, 2024

More digital health consolidation as Aptar buys Healint, a specialist in patient support apps and software to run virtual clinical trials and patient registries

108

108